优化CAR T疗法用于固体瘤的治疗
Norhan Mobark1,2, Caroline Malai Hull3, John Maher1,3,4
1King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Hospital, London, UK.
Expert review of anticancer therapy
|October 28, 2024
概括
化学抗原受体 (CAR) T细胞疗法在固体瘤中显示出前景. 向,交付和CAR设计方面的进展旨在克服瘤微环境的挑战,以获得有效的治疗.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物技术是生物技术.
背景情况:
- 采用仿制抗原受体 (CAR) 工程T细胞的采用免疫疗法对B细胞恶性瘤有效.
- 由于各种挑战,固体瘤在很大程度上仍然对CAR T细胞疗法具有抗性.
研究的目的:
- 审查用于部署CAR T细胞对抗固体瘤的技术进步.
- 确定克服CAR T细胞在固体瘤中的有效性障碍的策略.
主要方法:
- 在PubMed数据库的文献综述.
- 对固体瘤CAR T细胞治疗技术进步的分析.
主要成果:
- 开发复杂的向策略,以安全和全面地吸引固体瘤细胞.
- 改进的药物输送解决方案和新的CAR架构,以提高功能持久性.
- 考虑组合疗法,其中包括CAR T细胞.
结论:
- 目前正在取得显著的技术进步,以实现对固体瘤的CAR T细胞疗法.
- 解决瘤向,输送和瘤微环境方面的挑战对于临床成功至关重要.
相关概念视频
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K